olaparib,abiraterone
astrazeneca,merck
['docetaxel', 'brca', 'abira', 'olaparib', 'propel', 'prostate', 'abiraterone', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cam ']
bye bye to lynpaza's (and other parps') chances of an all-comers 1l prostate cancer label. os data for hrr-proficient subgroup in propel #gu23 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.